Healthy growth through and through

 
Financial market The investment company BB Medtech invests in concise advertising by Ruf Lanz. 
Advertising for banks, technology and finance companies does not always have to be technocratic. More and more often, it can also be creative. Last winter, Werbewoche wrote about a print campaign by Ruf Lanz for its new client BB Biotech. The asset management company behind BB Biotech is Bellevue Asset Management AG in Küsnacht, which together with Bank am Bellevue is part of Bellevue Group AG, and Ruf Lanz has now also been commissioned with the campaign for the investment company BB Medtech. BB Medtech invests in the most successful and promising companies in the growth market of medical technology. A team of doctors, scientists and financial specialists prepares investment decisions based on fundamental analysis.
The medical technology sector is growing at a good 10 percent per year. The number of people over the age of 65 is increasing by around 1 million per month. As life expectancy increases, so does the demand for medical care. New innovative products and technologies are driving developments in medicine: diseases should be detected more quickly and their treatment should be more effective. These facts mean that medical technology offers interesting long-term investment prospects. Since January 1, 2000, BB Medtech has achieved a share price performance of +157 percent.
As in the campaign for BB Biotech, Ruf Lanz managed to get to the heart of the complex topic in a surprising and intelligent way. For the time being, potential investors are being addressed with two large-format advertisements: The "Children's drawing" subject shows the even greater future demand for products in the medical technology sector because people are getting older and older. The subject "Hearing aids" dramatizes the performance without showing the usual price trends. The advertisements can be seen in business publications in Switzerland and Germany.
Andreas Panzeri